Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

therapeutics 864 - exam 1 > chemotherapy > Flashcards

chemotherapy Flashcards

1
Q

what is the median age of cancer diagnosis

A

67

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

t/f mortality is falling for cancer pts

A

true; we have gotten better at treating and curing cancer, and fewer environmental factors (smoking, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

def: new growth, may be benign or malignant

A

neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

def: nonspecific term meaning lump or swelling

A

tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

def: any malignant neoplasm

A

cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

increase in organ or tissue size due to an increase in # of cells

A

hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adaptive, substitution of 1 type of adult tissue to another type of adult tissue

A

metaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

an abnormal cellular proliferation is which there is loss of normal architecture

A

dysplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

loss of structural differentation. cells de-differentiate

A

anaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal epithelial tissues are very organized/disorganized?

A

organized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

name 2 synonyms for adenoma

A

benign & polyp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cancer nomenclature - the “______”

A

omas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

______ origin:
___________: malignant neoplasm of squamous cell (benign is _____)

A

epithelial
carcinoma; papilloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

______ origin:
___________: malignant neoplasm of glandular tissue (benign is _____)

A

epithelial
adenocarcinoma; adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

malignant neoplasm w origin in mesenchymal tissues or its derivatives (name 3 examples)

A

sarcoma (bone, muscle, fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

malignant neoplasms of hematopoietic tissues (2)

A

lymphoma & leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

type of cancer of pigment producing cells (melanocytes) in skin or eye (uveal)

A

melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

def: malignances in precursor cells, often call _______, which are more common in ______

A

blastoma; blasts; children (nephroblastoma, medulloblastoma, retinoblastoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

germ cell neoplasm made of several diff differentiated cell/tissue types

A

teratoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

6 yo boy has systemic malignancy orginating from precursor cells of nervous system. what would pathology report say?
a. adenocarcinoma
b. neuroblastoma
c. leukemia
d. metastatic sarcoma

A

b. neuroblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cancer is a disease of ______

A

progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

order of cancer progression

A

cell w mutation > hyperplasia > dysplasia > in situ cancer > invasive cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

cancer is characterized by what 3 things

A

uncontrolled cell growth
tissue invasion
metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

hallmarks of cancer
-sustaining _______ signaling
-avoiding _______ destruction
-enabling _______ immortality
-activating invasion & ________
-inducing or accessing _________
-genome instability & _______
-resisting cell ________

A

sustaining proliferative signaling
avoiding immune destruction
enablling replicative immortality
activating invasion & metastasis
inducing or accessing vasculature
genome instability & mutation
resisting cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

__________ is a cancer of WBC of hematopoietic origin

A

leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

for many tumors the growth of the _______ tumor is not going to be life threatening. these events can take place over periods of ________. metastasized cells are considered a ________ from the _______ site.

A

primary; years; tumor; primary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

t/f a tumor in the brain that originates from the breast is breast cancer not a brain cancer

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

more than ____% of cancer cases can be prevented. what is the primary cause?

A

40%; smoking (19%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

who was responsible for discovering that cancer could pass through a fine pore filter thus considering it to be a virus (RSV)?

A

peyton rous; chicken experiment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

RSV is a __________virus and integrates into the ________

A

retrovirus; genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

RSV encodes what protein?

A

v-SRC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

v-SRC is an ___________?

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

any gene in a healthy cell capable of promoting tumor growth is a _________

A

proto-oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

some cancers can result of __________ or __________ of a single potent _______ ________. some of these mutations run in families

A

mutation; deletion; tumor suppressor

35
Q

t/f childhood retinal cancer-retinal cells don’t stop dividing during development and form tumors (retinoblastoma)

A

true

36
Q

retinoblastoma is an example of Alred Knudsen’s ______ hypothesis

A

2-hit

37
Q

RB1 is a ______ _________

A

tumor suppressor

38
Q

most tumor suppressors can be expressed from either ________ and thus will need to be __________ deletion/mutation. Because of this, __________ mutations can be inherited and families show _________ susceptibility to cancers. Also called “_________________”

A

chromosome; homozygous; heterozygous; increased; loss of heterozygosity

39
Q

t/f often one mutation isn’t sufficient to cause cancer on its own

A

true

40
Q

p16 is a ________ __________

A

tumor suppressor

41
Q

most players can broadly be classified as _____ ________ or _______ depending on whether they _______ or ________ cancer. This classificiation doesn’t tell you much about molecular mechanisms

A

tumor suppressors; oncogenes; prevent or promote

42
Q

cancer classification arrives from the ______ of origin. tumors of the same classification can have a unifying genetic drive but often _____.
-100% of chronic myelogenous luekemia have cr-abl translocation
-non small cell lung cancer (NSCLC) is very heterogeneous collection of cancers

treatments are often determined ___________ and often only affect a subset of patients with the _____ cancer classification

A

tissue; do not
empirically; same

43
Q

NSCLC is non smokers median of ________ mutations. in smokers _________.

carcinogen induced cancers have very high mutation rates (bladder, lung, head & neck)

carcinogens include: _____ and ______

A

888; 15659; smoking & UV exposure

44
Q

most cancers are __________ & have a variety of gene mutations

A

heterogeneous

45
Q

BRCA1 and BRCA2 are _________ _________ that encode for proteins involved in _____ repair. They are inherited as _____ mutations and very prevalent in __________ ancestry

A

tumor suppressors; DNA; germline; Ashkenazi Jewish

46
Q

____% of NSCLC patients have an EGFR mutation

These mutations can be identified using sequencing technologies.

Mutations in EGFR catalytic domain __increase/decrease______ the intensity and duration of signaling in response to ligand. Activating mutations also increase the susceptibility to inhibitor almost _____ fold

A

15-30%; increase; 10

47
Q

BRCA mutations in breast cancer increase susceptibility to _______ inhibitors

A

PARP (poly ADP ribose polymerase)

48
Q

Olaparib is a ______ inhibitor and primarily treats cancers with _______ mutations. Works by trapping _____ to DNA.

Other drugs in class: rucaparib, niraparib, talazoparib, veliparib

A

PARP; BRCA1/2; PARP

49
Q

5 year overall cancer survival rate is ____%. Only a few cancers are typically curable by chemotherapy - _______ disease, some childhood leukemias and lymphomas, testicular cancer - 90% of all cancer cures by chemotherapy occur in a small number of total cancer types.

A

69%; Hodgkin’s disease

50
Q

What 3 cancer types are typically resistant to chemotherapy?

A

lung, pancreatic, brain

51
Q

Describe what happens in each cell cycle phase:
G0/G1:
S:
G2:

A

G0: cell not in cycle yet, but could be in future
G1: cell is quiescent or accumulating “building blocks” required for division
S: cell replicating DNA
G2: Cell assembling machinery for chromosomal segregation and cytokinesis

52
Q

The cell cycle clock is driven by _______paired with cyclin-dependent _______.

The ____ point is the critical time point when cells decide whether or not to enter cell cycle

A

cyclins; kinases; R

53
Q

List which drug classes target each phase of cell cycle
G1 (mitogenic signaling)
S (DNA replication
G2 (Sister chromatid separation)
M (chromosome segregation)

A

G1: kinase inhibitors, hormone inhibitors
S: anti-metabolites, anti-folates, topo1 inhibitors
G2: topo2 inhibitors
M: microtubule inhibitors

54
Q

which drug classes are non cell cycle specific (DNA damaging agents)

A

Alkylators & intercalaters

55
Q

Kras, HER2, PI3K are ______

A

oncogenes

56
Q

TP53, RB1 and P16 are

A

tumor suppressors

57
Q

what tumor suppressor is known as the guardian of the genome?

A

tp53

58
Q

Cyclin D and Cdk4,6 are master ________of cell cycle initiation

A

regulators

59
Q

Cyclin D can be inhibited by _____ _______, but if it is not, it can find CDK 4/6, which phosphorylates Rb1 which stops rb1 from working, which leads to ______formation

A

tumor suppressors; cancer

60
Q

what are the 3 CDK4/6 (cyclin dependent kinases) inhibitors

A

ribociclib, palbociclib, abemaciclib

61
Q

palbociclib is a _______ inhibitor
Although they are _____ inhibitors, they aren’t exactly “targeted therapies” because they target all replicating cells
Adverse reactions; ______penia, nausea, fatigue, diarrhea, vomiting (similar to traditional chemotherapies)
Approved for cancers arising due to ________ mutations

A

Cdk4/6 kinase; kinase; neutro; BRCA1/2

62
Q

Which of the following is potentially true of a tumor suppressor gene?

A. Allows unrestricted cell growth and proliferation.

B. Promotes different phases of the cell cycle.

C. Produces proteins that block the activity of cyclins.

D. Is often overexpressed in cancer

A

C

63
Q

Tumor cells have lost cell cycle control mechanisms which leads to
________cell proliferation.
____________controls are often lost as well

A

increased;Checkpoint

64
Q

When NORMAL cells are exposed to certain chemotherapy drugs that cause DNA damage
-Cells halt in ___ until DNA repaired
-Cells then proceed into S
-If cells proceed into S without repairing DNA, they _______ (programmed cell death)
-Preserves genomic integrity of daughter cells

When TUMOR cells that have lost _____ checkpoint control are treated with chemotherapy that causes ____ damage
-Cells don’t halt in G1 and attempt to replicate damaged DNA
-Attempting to replicate damaged DNA can trigger apoptosis
-or, if the apoptotic response has been lost cells replicate damaged DNA and acquire lethal genetic damage that results in _____(cell death that results in lysis and inflammation)

A

G1; apoptose
DNA; G1/S; necrosis

65
Q

Drugs that do not require cycling cells. These drugs are effective against cancer cells resting in ____ and cells progressing through the cell cycle.
>DNA alkylating agents can damage DNA __dependent/independent__of cell cycling

A

G0; independent

66
Q

Drugs that are more effective against cycling cells at many phases of the cell cycle are called cell cycle __________. These drugs are most effective when the tumor cells are progressing through the cell cycle. However, they are NOT dependent upon the cell being in a specific phase of the cell cycle. Many of these agents have some efficacy against cells resting in G0, but they are more effective against cells progressing through the cell cycle. The two drug classes are:

A

non-specific; Alkylating agents and DNA intercalation agents

67
Q

With a phase-specific agent, the number of cells killed by the agent will be limited to the number of cells present in the appropriate (“sensitive”) phase of the cell cycle. ___higher/lower____ drug doses may NOT result in greater tumor cell killing. Rather ___increased/decreased___ cell kill requires prolonged exposure. Two methods of prolonged exposure are:

A

Higher; repeated administration and continuous infusion

68
Q

What are the major dose-limiting toxicities associated with chemotherapy?

A

Hematopoietic- WBC (granulocytes) – infections, Platelets – hemostasis, RBC – anemia
Gastrointestinal, nausea & vomiting, loss of appetite

69
Q

A chemotherapy that interferes with DNA synthesis is

A S-phase specific

B G1-phase specific

C cell cycle non-specific

D M-phase specific

A

A S-phase specific

70
Q

Which phase of the cell cycle do you think is targeted by Palbociclib (the CDK4/6 inhibitor)?

A. G1

B. S

C. G2

D. M

A

A. G1
CDK4/6 inhibitors target cyclins responsible for cell checkpoints in G1 phase

71
Q

Cancer chemotherapy kills a constant _____, not a constant ______, of tumor cells

A

fraction; number

72
Q

t/f It is impossible to kill all tumor cells with a single dose of drug.

A

true

73
Q

Norton-Simon hypothesis
>Give as dose-intensive and early as possible
>Give chemotherapy at __shorter/longer___intervals
>Use combination of drugs with distinct mechanism of action

Explain why

A

shorter
As tumors grow, their doubling time slows-most anticancer agents work on cycling cells
When tumor burden is decreased, remaining will re-enter exponential growth
Diminishing returns- resistance and/or intolerable side effects

74
Q

Efficacy of cytotoxic chemotherapy
_____ relationship between tumor size and curability for many tumors.
In order for cancer chemotherapy to be successful, cell killing must be ___> or <___ than cell growth.

A

inverse, > (greater than)

75
Q

what are 3 factors that increase success rates of cytotoxic chemotherapy

A

-small tumors
-early diagnosis!!
-increased drug intensity

76
Q

t/f a drug that is ineffective when used alone is often NOT approved for combination studies

A

true, although this is changing
>individual drugs in combination should be used at max dose
>CHOP is a good example of a combo of drugs (cyclophosphamide -alkylating agent, doxorubicin-anthracycline, vincristine-microtubule inhibitor, prednisone-steroid)

77
Q

Cancer chemotherapy given as single agent results in either:
_________ or ________

Advantages of combination chemotherapy:
>No additive toxicity for drugs with _______________ toxicities
> __decreased/increased__ cell killing

A

drug resistance or drug toxicity
non overlapping, increased

78
Q

what are the 4 mechanisms of chemoresistance

A
  1. Increased transport of drugs out of the cell through efflux pumps
    >P-Glycoprotein (PgP)
    >Multi-drug resistance -associated protein (MRP)
  2. Reduced transport into the cell
    >Loss of drug importer, decreased membrane permeability
  3. Decreased activation of prodrug
  4. Increased detoxification of drug molecule
79
Q

what are 3 ways the drug target or function can change?

A

1- Increased expression of drug target through gene amplification or expression
>Upregulation of a drug target makes it harder to inhibit

2- Emergence of mutant, structurally altered target
>Mutants that are still active but don’t bind the drug

3- Emergence of cells bearing alterations in genes whose products are functionally redundant with the drug target
>Cells can rewire pathways to bypass the need for the drug target

80
Q

what are 3 physiological changes that promote resistance

A

Refuge of cancer cells in drug-protected anatomical sites
>Metastasis to the brain where drugs do not cross blood-brain barrier

Massive stromalization
>Pancreatic carcinomas develop highly desmoplastic stroma that impedes drug transport

Changes in cell state such as EMT (epithelial mesenchymal transition)
>Slows cell cycle, increases drug efflux pumps and increases anti-apoptotic proteins

81
Q

what are the 2 cell survival mechanisms

A

1- Activation of anti-apoptotic regulators
>Increase in proteins that help cancer cells bypass cell death

2- Increased repair of damage caused by chemotherapies.
>Most common is the repair of drug-DNA adducts or DNA damage

82
Q

What is the most common reason for resistance to multiple chemotherapies at once?

A. Decreased activation of prodrugs

B. Drug transport out of cells

C. Cell cycle changes

D. Mutations in drug targets

A

B. Drug transport out of cells

most chemotherapies are NOT prodrugs
not all target cell cycle

83
Q

what are the 2 limitations of chemotherapy

A

resistance & toxicity

Cancer chemotherapy relies on general principle that tumor cells are more sensitive to drugs than normal cells

Therapeutic index: ratio of the dose of a drug that is toxic to normal cells and the dose of a drug that is toxic to cancer cells

84
Q

t/f BRCA & PARP are tumor suppressor genes

A

true

if someone already has a BRCA mutation, only PARP works to suppress tumors, so PARP inhibitors can block this, so no repair happens & causes cell death

therapeutics 864 - exam 1 (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions